Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.
about
Biomarker development in MET-targeted therapyMET inhibitors for treatment of advanced hepatocellular carcinoma: A reviewCD151-A Striking Marker for Cancer TherapyTetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysisEpigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancerProfiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection.Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinomaStructure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.Overexpression of CD151 predicts prognosis in patients with resected gastric cancer.Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Promoting colonization in metastatic HCC cells by modulation of autophagyPreclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.Genomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma.Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinomac-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinomaHigh expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resectionMolecular diagnosis of intrahepatic cholangiocarcinoma.The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7Application of RNA-Seq transcriptome analysis: CD151 is an Invasion/Migration target in all stages of epithelial ovarian cancer.Clinical significance of CD151 overexpression in subtypes of invasive breast cancer.Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer.Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in gliomaTargeting the HGF-cMET Axis in Hepatocellular Carcinoma.Matrix metalloproteinase-9 in the initial injury after hepatectomy in mice.Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinomaGeneration and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC.High level of αB-crystallin contributes to the progression of osteosarcomaHigh level of BRD4 promotes non-small cell lung cancer progression.miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.Downregulation of coding transmembrane protein 35 gene inhibits cell proliferation, migration and cell cycle arrest in osteosarcoma cellsIn-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2.miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transitionDecreased expression of GATA2 promoted proliferation, migration and invasion of HepG2 in vitro and correlated with poor prognosis of hepatocellular carcinoma.
P2860
Q26751332-9CAB646D-98B2-453C-928E-589B6C20F80CQ27014423-8AA45D47-2F28-4F7E-84C7-490174635394Q27024979-22B4F265-A035-4FF1-9E4B-662490CD1DDAQ28071547-875ADBB2-EA7B-4771-9B1B-78D3F1C811C7Q31118547-B9882058-8CEA-4F10-9475-5F2A0AD4BCDFQ33769437-068FCC66-85B0-4C39-8344-59FD8991350DQ33886974-526AC4BC-26DF-4ADB-963E-5B12889BE0FFQ34035858-74E7F307-6F8A-47C4-99B3-1A354BC1D37CQ34200028-95E23B1E-C8DC-4316-8C97-7CA8BCAEF5B1Q34563366-1EEC0F22-72B2-4E59-BEDC-672F6DBB655FQ34606382-82EB1016-B6B8-4101-A3E5-96DAB3BEDD1EQ34637700-D7BBC671-DC77-44A5-BBDD-81A18B0E2D0FQ34914039-DA879F38-13A4-4472-B28C-663EA729B215Q34994660-87FAB244-84CA-4EDD-BDCA-41BA68B8B292Q34995167-DF6A02CA-14FF-482F-988C-E9A989631B26Q35112679-C772FCD7-D7EB-4F20-819A-9BF8C788D49BQ35166443-8DB8A19C-D45C-415F-9C01-2F64593E8872Q35234688-F424C872-CBA8-4D3B-BD11-37E8828461E9Q35235798-C46D2D90-C2F5-4260-AE0F-345346358C3DQ35584172-9C92C45A-2596-4B42-B033-8F0463DDEDA5Q35592221-34AB776D-C724-4831-826D-BC053DE8EFEBQ35636713-70CFD78E-01A3-43DF-B5DB-9864368A3247Q35726284-87408963-45B1-4F20-8304-E57A37A23518Q35785330-722AF86F-6076-4D97-AF7C-A667FB0005D2Q35837603-0F091AA3-6ECE-4802-80DA-6AD0538CA478Q36075407-F5FE06B9-26BB-4F65-84B6-E5273892D813Q36476417-3C112615-4849-4EE9-8FCA-022694A4B485Q36766188-19DE94E9-F5F2-4E87-A510-AC5E487A56DBQ36871980-89290B93-8BF7-4C8C-ADFC-3D1F4CC51F78Q36905652-31689828-3382-4C4A-A92B-C4A7D0374BD8Q36905908-50EEE6C4-F3D2-44B1-B384-E0CF3F3A8CF9Q36962484-D058AE45-D055-4074-BCB9-E10A40F753A9Q36962647-F01E7FCF-78D2-4A64-A91D-F68863877C44Q36983766-761CAC6B-2530-4C15-83F4-D3B40A7501DBQ37106752-17C60C3D-C1E6-48EB-8DCE-C9F836219FDBQ37225469-361A7A79-10D1-42A5-9737-13ADC94A0B6CQ37362811-15249304-4697-4B2E-948E-EEAF66828B0BQ37376531-7823EDE4-9D3D-46C1-9234-BA8EB5880609Q37440060-C52F259D-093D-4707-B2C5-C87781F548F2Q37534541-481DCEC0-E09F-40F6-B35B-F15EC92FD5B2
P2860
Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@en
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@nl
type
label
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@en
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@nl
prefLabel
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@en
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Role of overexpression of CD15 ...... s of hepatocellular carcinoma.
@en
P2093
Dou-Sheng Bai
Fei-Zhen Wu
Guo-Ming Shi
Jia-Chu Li
Jin-Cai Wu
Kang-Da Liu
P2860
P304
P356
10.1002/HEP.22639
P407
P577
2009-02-01T00:00:00Z